Dossier Preparation
We compile the full HIRA application — including clinical evidence review, health technology assessment (HTA) support, and economic justification — structured to meet HIRA committee review standards.
HIRA Reimbursement
Insurance Listing Is Where Korean Market Revenue Is Won or Lost.
Without HIRA listing, Korean hospitals cannot reimburse your device — and most will not buy it.
Pricing Strategy & Negotiation
We advise on reimbursement pricing strategy, prepare the negotiation dossier, and represent your position through the HIRA pricing committee process to achieve a commercially viable listing price.
Listing Management
We manage all HIRA correspondence, track listing status, and handle any re-evaluation or pricing renegotiation requirements after initial listing is confirmed.
Service specification
Korea HIRA Reimbursement
All documentation and outcomes needed to achieve and maintain HIRA reimbursement listing.
Request assessmentWithout HIRA listing, a device is locked out of the mainstream Korean hospital market. The dossier, economic justification, and committee negotiation require expertise beyond standard regulatory filing.
HIRA application dossier with clinical and economic evidence
Health technology assessment (HTA) summary
Economic justification report
Pricing strategy memo and negotiation record
HIRA listing confirmation and official reimbursement code
Frequently Asked Questions
Common questions about HIRA reimbursement listing in Korea.